Clinical Trial Update: Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study evaluating hydroxyurea and metformin in transfusion-dependent beta-thalassemia, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transfusion-dependent Beta-thalassemia

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)
• metformin (metformin)

Snippet

Sponsor: Ayesha Khan | Conditions: Transfusion Dependent Beta-thalassemia | Phase 4 | Status: COMPLETED